Cell surface self-assembly of hybrid nanoconjugates via oligonucleotide hybridization induces apoptosis

ACS Nano

Volumn 8, Issue 1, 2014, Pages 719-730

  Chu, Te Wei ^a   Yang, Jiyuan ^a   Zhang, Rui ^a   Sima, Monika ^a   Kopeček, Jindřich ^a,b  

^a UNIVERSITY OF UTAH   (United States)

^b Department of Electrical and Computer Engineering   (United States)

Author keywords

apoptosis; B cell lymphoma; biorecognition; CD20; morpholino oligonucleotide; N (2 hydroxypropyl)methacrylamide (HPMA); receptor cross linking

Indexed keywords

B-CELL LYMPHOMA; BIO RECOGNITION; CD20; METHACRYLAMIDES; RECEPTOR CROSS-LINKING;

ANTIGENS; CELL DEATH; CELL MEMBRANES; CHEMOTHERAPY; NANOSTRUCTURED MATERIALS; OLIGONUCLEOTIDES; ONCOLOGY;

NANOCONJUGATES;

CD20 ANTIGEN; HYDROXYPROPYL METHACRYLATE; IMMUNOGLOBULIN FRAGMENT; METHACRYLIC ACID DERIVATIVE; MORPHOLINO OLIGONUCLEOTIDE; NANOCONJUGATE;

ANIMAL; APOPTOSIS; ARTICLE; B CELL LYMPHOMA; CELL MEMBRANE; CHEMISTRY; CIRCULAR DICHROISM; DRUG SCREENING; FEMALE; HUMAN; IMMUNOLOGY; METABOLISM; MOUSE; NUCLEIC ACID HYBRIDIZATION; PATHOLOGY; SCID MOUSE;

ANIMALS; ANTIGENS, CD20; APOPTOSIS; CELL MEMBRANE; CIRCULAR DICHROISM; DRUG SCREENING ASSAYS, ANTITUMOR; FEMALE; HUMANS; IMMUNOGLOBULIN FRAGMENTS; LYMPHOMA, B-CELL; METHACRYLATES; MICE; MICE, SCID; MORPHOLINOS; NANOCONJUGATES; NUCLEIC ACID HYBRIDIZATION;

EID: 84893476813     PISSN: 19360851     EISSN: 1936086X     Source Type: Journal    
DOI: 10.1021/nn4053827     Document Type: Article

References (58)

1. Douglas, S. M.; Bachelet, I.; Church, G. M. A Logic-Gated Nanorobot for Targeted Transport of Molecular Payloads Science 2012, 335, 831-834
2. Mulvey, J. J.; Villa, C. H.; McDevitt, M. R.; Escorcia, F. E.; Casey, E.; Scheinberg, D. A. Self-Assembly of Carbon Nanotubes and Antibodies on Tumours for Targeted Amplified Delivery Nat. Nanotechnol. 2013, 8, 763-771
3. Lu, Z. R.; Kopečková, P.; Kopeček, J. Polymerizable Fab′ Antibody Fragments for Targeting of Anticancer Drugs Nat. Biotechnol. 1999, 17, 1101-1104
4. Gungormus, M.; Branco, M.; Fong, H.; Schneider, J. P.; Tamerler, C.; Sarikaya, M. Self Assembled Bi-Functional Peptide Hydrogels with Biomineralization-Directing Peptides Biomaterials 2010, 31, 7266-7274
5. Holmes, T. C.; de Lacalle, S.; Su, X.; Liu, G.; Rich, A.; Zhang, S. Extensive Neurite Outgrowth and Active Synapse Formation on Self-Assembling Peptide Scaffolds Proc. Natl. Acad. Sci. U.S.A. 2000, 97, 6728-6733
6. Yuan, W.; Yang, J.; Kopečková, P.; Kopeček, J. Smart Hydrogels Containing Adenylate Kinase: Translating Substrate Recognition into Macroscopic Motion J. Am. Chem. Soc. 2008, 130, 15760-15761
7. Ehrick, J. D.; Deo, S. K.; Browning, T. W.; Bachas, L. G.; Madou, M. J.; Daunert, S. Genetically Engineered Protein in Hydrogels Tailors Stimuli-Responsive Characteristics Nat. Mater. 2005, 4, 298-302
8. Liu, J.; Mazumdar, D.; Lu, Y. A Simple and Sensitive "Dipstick" Test in Serum Based on Lateral Flow Separation of Aptamer-Linked Nanostructures Angew. Chem., Int. Ed. 2006, 45, 7955-7959
9. Wu, K.; Liu, J.; Johnson, R. N.; Yang, J.; Kopeček, J. Drug-Free Macromolecular Therapeutics: Induction of Apoptosis by Coiled-Coil-Mediated Cross-Linking of Antigens on the Cell Surface Angew. Chem., Int. Ed. 2010, 49, 1451-1455
10. Cho, M. H.; Lee, E. J.; Son, M.; Lee, J. H.; Yoo, D.; Kim, J. W.; Park, S. W.; Shin, J. S.; Cheon, J. A Magnetic Switch for the Control of Cell Death Signalling in in Vitro and in Vivo Systems Nat. Mater. 2012, 11, 1038-1043
11. Kopeček, J.; Yang, J. Smart Self-Assembled Hybrid Hydrogel Biomaterials Angew. Chem., Int. Ed. 2012, 51, 7396-7417
12. Siegel, R.; Naidsham, D.; Jemal, A. Cancer Statistics 2013 CA Cancer J. Clin. 2013, 63, 11-30
13. Cheson, B. D.; Leonard, J. P. Monoclonal Antibody Therapy for B-Cell Non-Hodgkin's Lymphoma N. Engl. J. Med. 2008, 359, 613-626
14. Molina, A. A Decade of Rituximab: Improving Survival Outcomes in Non-Hodgkin's Lymphoma Annu. Rev. Med. 2008, 59, 237-250
15. Cartron, G.; Dacheux, L.; Salles, G.; Solala-Celigny, P.; Bardos, P.; Colombat, P.; Watier, H. Therapeutic Activity of Humanized Anti-CD20 Monoclonal Antibody and Polymorphism in IgG Fc Receptor FcγRIIIa Gene Blood 2002, 99, 754-758
16. Smith, M. R. Rituximab (Monoclonal Anti-CD20 Antibody): Mechanisms of Action and Resistance Oncogene 2003, 22, 7359-7368
17. Allison, M. PML Problems Loom for Rituxan Nat. Biotechnol. 2010, 28, 105-106
18. Lands, L. C. New Therapies, New Concerns: Rituximab-Associated Lung Injury Pediatr. Nephrol. 2010, 25, 1001-1003
19. Kamei, K.; Ito, S.; Iijima, K. Severe Respiratory Adverse Events Associated with Rituximab Infusion Pediatr. Nephrol. 2010, 25, 1193
20. van der Kolk, L. E.; Grillo-López, A. J.; Baars, J. W.; Hack, C. E.; van Oers, M. H. Complement Activation Plays a Key Role in the Side-Effects of Rituximab Treatment Br. J. Hamaetol. 2001, 115, 807-811
21. Shimizu, Y.; van Seventer, G. A.; Ennis, E.; Newman, W.; Horgan, K. J.; Shaw, S. Crosslinking of the T Cell-Specific Accessory Molecules CD7 and CD28 Modulates T Cell Adhesion J. Exp. Med. 1992, 175, 577-582
22. Vallat, L. D.; Park, Y.; Li, C.; Gribben, J. G. Temporal Genetic Program Following B-Cell Receptor Cross-Linking: Altered Balance Between Proliferation and Death in Healthy and Malignant B Cells Blood 2007, 109, 3989-3997
23. Kahn, C. R.; Baird, K. L.; Jarrett, D. B.; Flier, J. S. Direct Demonstration That Receptor Crosslinking or Aggregation Is Important in Insulin Action Proc. Natl. Acad. Sci. U.S.A. 1978, 75, 4209-4213
24. Deans, J. P.; Li, H.; Polyak, M. J. CD20-Mediated Apoptosis: Signalling through Lipid Rafts Immunology 2002, 107, 176-182
25. Nielsen, P. E. DNA Analogues with Nonphosphodiester Backbones Annu. Rev. Biophys. Biomol. Struct. 1995, 24, 167-183
26. Summerton, J.; Weller, D. Morpholino Antisense Oligomers: Design, Preparation, and Properties Antisense Nucleic Acid Drug Dev. 1997, 7, 187-195
27. Liu, G.; He, J.; Dou, S.; Gupta, S.; Vanderheyden, J. L.; Rusckowski, M.; Hnatowich, D. J. Pretargeting in Tumored Mice with Radiolabeled Morpholino Oligomer Showing Low Kidney Uptake Eur. J. Nucl. Med. Mol. Imaging 2004, 31, 417-424
28. 99mTc- Labeled Morpholinos for Radiopharmaceutical Applications Eur. J. Nucl. Med. 2001, 28, 1682-1689
29. Kopeček, J.; Kopečková, P. HPMA Copolymers: Origins, Early Developments, Present, and Future Adv. Drug Delivery Rev. 2010, 62, 122-149
30. Ulbrich, K.; Šubr, V. Structural and Chemical Aspects of HPMA Copolymers as Drug Carriers Adv. Drug Delivery Rev. 2010, 62, 150-166
31. Stashenko, P.; Nadler, L. M.; Hardy, R.; Schlossman, S. F. Characterization of a Human B Lymphocyte-Specific Antigen J. Immunol. 1980, 125, 1678-1685
32. Anderson, K. C.; Bates, M. P.; Slaughenhoupt, B. L.; Pinkus, G. S.; Schlossman, S. F.; Nadler, L. M. Expression of Human B Cell-Associated Antigens on Leukemias and Lymphomas: A Model of Human B Cell Differentiation Blood 1984, 63, 1424-1433
33. Kimby, E. Tolerability and Safety of Rituximab (MabThera®) Cancer Treat. Rev. 2005, 31, 456-473
34. Press, O. W.; Appelbaum, F.; Ledbetter, J. A.; Martin, P. J.; Zarling, J.; Kidd, P.; Thomas, E. D. Monoclonal Antibody 1F5 (Anti-CD20) Serotherapy of Human B Cell Lymphomas Blood 1987, 69, 584-591
35. Johnson, W. C. CD of Nucleic Acids. In Circular Dichroism: Principles and Applications, 2 nd ed.; Berova, N.; Nakanishi, K.; Woody, R. W., Eds.; Wiley-VCH: New York, 2000; pp 703-718.
36. Shan, D.; Ledbetter, J. A.; Press, O. W. Apoptosis of Malignant Human B Cells by Ligation of CD20 with Monoclonal Antibodies Blood 1998, 91, 1644-1652
37. Ben-Bassat, H.; Goldblum, N.; Mitrani, S.; Goldblum, T.; Yoffey, J. M.; Cohen, M. M.; Bentwich, Z.; Ramot, B.; Klein, E.; Klein, G. Establishment in Continuous Culture of a New Type of Lymphocyte from a "Burkitt Like" Malignant Lymphoma (Line D.G.-75) Int. J. Cancer 1977, 19, 27-33
38. Johnson, R. N.; Kopečková, P.; Kopeček, J. Synthesis and Evaluation of Multivalent Branched HPMA Copolymer-Fab′ Conjugates Targeted to the B-Cell Antigen CD20 Bioconjugate Chem. 2009, 20, 129-137
39. Johnson, R. N.; Kopečková, P.; Kopeček, J. Biological Activity of Anti-CD20 Multivalent HPMA Copolymer-Fab′ Conjugates Biomacromolecules 2012, 13, 727-735
40. Chu, T.-W.; Yang, J.; Kopeček, J. Anti-CD20 Multivalent HPMA Copolymer-Fab′ Conjugates for the Direct Induction of Apoptosis Biomaterials 2012, 33, 7174-7181
41. Ghetie, M. A.; Richardson, J.; Tucker, T.; Jones, D.; Uhr, J. W.; Vitetta, E. S. Disseminated or Localized Growth of a Human B-Cell Tumor (Daudi) in SCID Mice Int. J. Cancer 1990, 45, 481-485
42. Ghetie, M. A.; Tucker, K.; Richardson, J.; Uhr, J. W.; Vitetta, E. S. The Antitumor Activity of an Anti-CD22 Immunotoxin in SCID Mice with Disseminated Daudi Lymphoma Is Enhanced by Either an Anti-CD19 Antibody or an Anti-CD19 Immunotoxin Blood 1992, 80, 2315-2320
43. Griffiths, G. L.; Mattes, M. J.; Stein, R.; Govindan, S. V.; Horak, I. D.; Hansen, H. J.; Goldenberg, D. M. Cure of SCID Mice Bearing Human B-Lymphoma Xenografts by an Anti-CD74 Antibody-Anthracycline Drug Conjugate Clin. Cancer Res. 2003, 9, 6567-6571
44. Wu, K.; Yang, J.; Liu, J.; Kopeček, J. Coiled-Coil Based Drug-Free Macromolecular Therapeutics: In Vivo Efficacy J. Controlled Release 2012, 157, 126-131
45. Okroj, M.; Österborg, A.; Blom, A. M. Effector Mechanisms of Anti-CD20 Monoclonal Antibodies in B Cell Malignancies Cancer Treat. Rev. 2013, 39, 632-639
46. Chen, W. C.; Completo, G. C.; Sigal, D. S.; Crocker, P. R.; Saven, A.; Paulson, J. C. In Vivo Targeting of B-Cell Lymphoma with Glycan Ligands of CD22 Blood 2010, 115, 4778-4786
47. Goodwin, D. A.; Meares, C. F. Advances in Pretargeting Biotechnology Biotechnol. Adv. 2001, 19, 435-450
48. Gunn, J.; Park, S. I.; Veiseh, O.; Press, O. W.; Zhang, M. A Pretargeted Nanoparticle System for Tumor Cell Labeling Mol. BioSyst. 2011, 7, 742-748
49. Zhou, J.; Soontornworajit, B.; Snipes, M. P.; Wang, Y. Development of a Novel Pretargeting System with Bifunctional Nucleic Acid Molecules Biochem. Biophys. Res. Commun. 2009, 386, 521-525
50. Zhang, N.; Khawli, L. A.; Hu, P.; Epstein, A. L. Generation of Rituximab Polymer May Cause Hyper-Cross-Linking-Induced Apoptosis in Non-Hodgkin's Lymphomas Clin. Cancer Res. 2005, 11, 5971-5980
51. Herter, S.; Herting, F.; Mundigl, O.; Waldhauer, I.; Weinzierl, T.; Fauti, T.; Muth, G.; Ziegler-Landesberger, D.; Van Puijenbroek, E.; Lang, S. et al. Preclinical Activity of the Type II CD20 Antibody GA101 (Obinutuzumab) Compared with Rituximab and Ofatumumab In Vitro and in Xenograft Models Mol. Cancer Ther. 2013, 12, 2031-2042
52. Nguyen, J. T.; Evans, D. P.; Galvan, M.; Pace, K. E.; Leitenberg, D.; Bui, T. N.; Baum, L. G. CD45 Modulates Galectin-1-Induced T Cell Death: Regulation by Expression of Core 2 O -Glycans J. Immunol. 2001, 167, 5697-5707
53. Gu, Z.; Yamashiro, J.; Kono, E.; Reiter, R. E. Anti-Prostate Stem Cell Antigen Monoclonal Antibody 1G8 Induces Cell Death in Vitro and Inhibits Tumor Growth in Vivo via a Fc-Independent Mechanism Cancer Res. 2005, 65, 9495-9500
54. Fowers, K. D.; Callahan, J.; Byron, P.; Kopeček, J. Preparation of Fab′ from Murine IgG2a for Thiol Reactive Conjugation J. Drug Targeting 2001, 9, 281-294
55. Pan, H.; Yang, J.; Kopečková, P.; Kopeček, J. Backbone Degradable Multiblock N -(2-Hydroxypropyl)methacrylamide Copolymer Conjugates via Reversible Addition-Fragmentation Chain Transfer Polymerization and Thiol-Ene Coupling Reaction Biomacromolecules 2011, 12, 247-252
56. Kopeček, J.; Bažilová, H. Poly[ N -(2-hydroxypropyl)methacrylamide]-I. Radical Polymerization and Copolymerization Eur. Polym. J. 1973, 9, 7-14
57. Šubr, V.; Ulbrich, K. Synthesis and Properties of New N -(2-Hydroxypropyl)methacrylamide Copolymers Containing Thiazolidine-2-thione Reactive Groups React. Funct. Polym. 2006, 66, 1525-1538
58. Omelyanenko, V.; Kopečková, P.; Gentry, C.; Kopeček, J. Targetable HPMA Copolymer-Adriamycin Conjugates. Recognition, Internalization, and Subcellular Fate J. Controlled Release 1998, 53, 25-37